1. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients
    Andrea Mareckova et al, 2019, Leukemia & Lymphoma CrossRef
  2. New developments in the pathology of malignant lymphoma. A review of the literature published from September–August 2017
    J. H. van Krieken, 2017, Journal of Hematopathology CrossRef
  3. Evidence-based review of genomic aberrations in diffuse large B cell lymphoma, not otherwise specified (DLBCL, NOS): Report from the cancer genomics consortium lymphoma working group
    Ashwini K. Yenamandra et al, 2022, Cancer Genetics CrossRef
  4. Prognostic and therapeutic value of somatic mutations in diffuse large B-cell lymphoma: A systematic review
    Maria Lopez-Santillan et al, 2021, Critical Reviews in Oncology/Hematology CrossRef
  5. Association of p53 protein expression with the presence of a 17p13 locus deletion of the TP53 gene and with the survival of patients with diffuse large B-cell lymphoma
    Mariia V. Sarpova et al, 2023, Kazan medical journal CrossRef
  6. Comparative High-Resolution Transcriptome Sequencing of Lymphoma Cell Lines and de novo Lymphomas Reveals Cell-Line-Specific Pathway Dysregulation
    Leila Taher et al, 2018, Scientific Reports CrossRef
  7. Progress in molecular feature of smoldering mantle cell lymphoma
    Panruo Jiang et al, 2021, Experimental Hematology & Oncology CrossRef
  8. Prognostic significance of p53, Sox11, and Pax5 co-expression in mantle cell lymphoma
    Caixia Jing et al, 2021, Scientific Reports CrossRef
  9. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis
    Holly A. Hill et al, 2020, Blood Advances CrossRef
  10. Mitochondria and Their Relationship with Common Genetic Abnormalities in Hematologic Malignancies
    Ibolya Czegle et al, 2021, Life CrossRef
  11. Role of RNA Splicing Mutations in Diffuse Large B Cell Lymphoma
    Dereje Berta et al, 2023, International Journal of General Medicine CrossRef